Two new Covid vaccines and one antiviral drug approved in India

Two new Covid vaccines and one antiviral drug approved in India

Daily Current Affairs   /   Two new Covid vaccines and one antiviral drug approved in India

Change Language English Hindi

Category : National Published on: December 29 2021

Share on facebook
  • The use of two new Covid vaccines as well as an antiviral oral medicine has been approved by the Central Drugs Standard Control Organization.
  • The names of these two covid vaccines are CORBEVAX and COVOVAX, and the antiviral drug is Molanupiravir. Molanupiravir is recommended to be taken only in case of emergency.
  • Corbevax Vaccine is an RBD protein subunit vaccine produced in India by Biological E, a Hyderabad-based company. COVOVAX Vaccine is manufactured by Serum Institute.
  • The total number of vaccines approved for emergency use has now risen to eight.
  • Covishield, Covaxin, Sputnik V, Moderna, Johnson & Johnson, and ZyCoV-D are the only Vaccine that have received approval so far.
Recent Post's
  • India halts auction of Lord Buddha’s sacred Piprahwa Relics in Hong Kong, sends legal notice to Sotheby’s.

    Read More....
  • UNSC raises concern over Pakistan's missile tests and LeT links in Pahalgam attack.

    Read More....
  • Russia declares May 8–10 ceasefire for WWII Victory Day; Ukraine rejects it as political stunt.

    Read More....
  • C-DOT and CSIR-NPL sign MoU to boost joint research in classical and quantum communication.

    Read More....
  • Cabinet approves revised SHAKTI policy to grant coal linkages to thermal power plants.

    Read More....
  • INS Kiltan joins IMDEX Asia 2025 in Singapore to strengthen India–Singapore maritime ties.

    Read More....
  • Cabinet approves National Scheme for ITI upgradation and five National Skilling Centres.

    Read More....
  • Indian forces conduct 24 precision strikes on Pakistan-based terror infrastructure.

    Read More....
  • Rohit Sharma announces retirement from Test cricket, continues with ODIs.

    Read More....
  • Moody’s lowers India’s 2025 GDP growth forecast to 6.3% citing global headwinds.

    Read More....